Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Myriad Genetics, Inc.

Myriad Genetics is a biopharmaceutical company focused on the development of novel healthcare products. In addition to an expanding preclinical pipeline, their drug discovery and development is strong in the areas of cancer and antivirals.

Search Projects

  • Vice President, Research